Production of Foot-and-Mouth Disease Type O and A Vaccine Antigens on a Pilot Scale and Determination of Optimal Amount of Antigen for Monovalent Vaccines
Authors:
- Jae Young KimJKJae Young Kim
- Ji-Hye LeeJLJi-Hye Lee
- Jong Min YangJYJong Min Yang
- Seo-Yong LeeSLSeo-Yong Lee
- Sun Young ParkSPSun Young Park
- Jong Sook JinJJJong Sook Jin
- Dohyun KimDKDohyun Kim
- Jung-Won ParkJPJung-Won Park
- Jong-Hyeon ParkJPJong-Hyeon Park
- Sang Hyun ParkSPSang Hyun Park
- Young-Joon KoYKYoung-Joon Ko
Open Access
Abstract
Foot-and-mouth disease (FMD) is a highly infectious disease affecting cloven-hoofed animals and causes significant economic losses to the livestock industry. The Type O PanAsia-2 (O PA-2) vaccine strain is protective against a wide range of serotype O FMD virus (FMDV) strains in East Asia, and A22 Iraq/24/64 (A22 IRQ) is the most widely used vaccine strain in FMD vaccine antigen banks. The aim of this study was to produce antigens from O PA-2 and A22 IRQ viruses using a 100 L bioreactor and evaluate the protective efficacy of varying antigen concentrations in pigs. More than 2 μg/mL of the antigen was recovered from the O PA-2 and A22 IRQ virus-infected supernatants. Further, inactivation of O PA-2 and A22 IRQ by binary ethyleneimine revealed that the viral titers decreased below 10−7 TCID50/mL within 13 h and 9 h, respectively. The O PA-2 and A22 IRQ vaccines, containing 10 μg and 5 μg of antigen, respectively, provided protection against homologous viruses in pigs. This is the first report demonstrating that the antigens obtained from the pilot-scale production of O PA-2 and A22 IRQ are viable candidate vaccines. These results will pave the way for industrial-scale FMD vaccine production in South Korea.Keywords
Funding Information
- Animal and Plant Quarantine Agency (N-1543386-2023-25-01)
This publication has 18 references indexed in Scilit:
- Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010/2011Vaccine, 2014
- The economic impacts of foot and mouth disease – What are they, how big are they and where do they occur?Preventive Veterinary Medicine, 2013
- A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free CountriesTransboundary and Emerging Diseases, 2013
- Innate Immune Defenses Induced by CpG Do Not Promote Vaccine-Induced Protection against Foot-and-Mouth Disease Virus in PigsClinical and Vaccine Immunology, 2009
- Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccineBiologicals, 2004
- Molecular basis of pathogenesis of FMDVVirus Research, 2003
- FMD vaccinesVirus Research, 2003
- Effect of formaldehyde and binary ethyleneimine (BEI) on the integrity of foot and mouth disease virus capsidScientific and Technical Review, 1989
- A simple method for the quantification of 140 s particles of foot-and-mouth disease virus (FMDV)Archives of Virology, 1974
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedeberg's Archives of Pharmacology, 1931